Report Detail
Sickle Cell Disease Drug Market By Drug Type ( Antibiotics, Hydroxyurea, Pain-relieving medications ), By Mode of Administration ( Oral, Intravenous ), By Disease Type ( Sickle cell anemia, Sickle beta thalassemia, Sickle hemoglobin c disease ), By Distribution Channel ( Retail pharmacies, Hospital pharmacies, Online pharmacies ), Industry Trends, Estimation & Forecast, 2017 - 2025
- RnM3857882 |
- 23 December, 2019 |
- Global |
- 112 Pages |
- Esticast Research & Consulting |
- Healthcare
The research report offers a comprehensive picture of the Sickle Cell Disease Drug market. The report initiates with the executive summary of the market that includes market definition, recent industry trends, and developments, strategies of the key players and wide product offerings. Moreover, the study explains the future opportunities and a sketch of the key participants actively operating in the market.
About Sickle Cell Disease Drug Market
Sickle cell disease refers to a set of inherited diseases that cause the transformation of disc shaped red blood cells into a sickle shaped cells. It is an umbrella term for disease such as sickle cell anemia, sickle hemoglobin C disease, and sickle beta thalassemia. Numerous developments occurring in the industry related to sickle cell disease has led the sickle cell disease drug market to emerge as a lucrative market. Market players are continuously striving to achieve success in developing a permanent drug that can cure the disease. The global sickle cell disease drug market is experiencing hurdles in its growth, owing to the unavailability of drugs in the rural areas of developing nations, malpractices occurring in drug sales, and availability of few FDA approved drugs for sickle cell anemia.
The research report is prepared based on the combination of qualitative as well as quantitative aspects. By thorough understanding, the report is fragmented by larger ratios. The report covers in-depth analysis with major factors such as drivers, restraints, opportunities, and challenges that influences the growth of the market. On the other hand, The Sickle Cell Disease Drug report presents data starting from the base year 2018, historical year: 2014-2018, estimated the year 2019 and Forecast year from 2019 to 2026.
The Sickle Cell Disease Drug market report offers the market size and estimates the forecast from 2019-2026. The forecast estimation is predicted based on the key regions that include North America, Europe, Asia Pacific, Middle East, South America, and the Middle East & Africa. Furthermore, the Sickle Cell Disease Drug report provides a deep emphasis on secondary tools used to document the report. PEST analysis, SWOT, Porter’s Five Forces, and others are considered by the analysts while preparing the report.
Scope and Segmentation of the Market
Based on Type
By Drug Type
Antibiotics
Hydroxyurea
Pain-relieving medications
Others
Based on Application
Retail pharmacies
Hospital pharmacies
Online pharmacies
Each segment of the Sickle Cell Disease Drug market is extensively evaluated in the research study. The segment analysis covered in the report aims at the key opportunities available in the Sickle Cell Disease Drug market report by leading segments. In addition, the research report offers market dynamics for the market that influences qualitative as well as quantitative research.
Research Methodology
The report follows a comprehensive and rigorous research methodology to provide you accurate estimates and forecasts of a particular market. The report provide estimates, forecast, and analysis primarily based on secondary research, primary interviews, in-house database and other free as well as paid sources. In addition, the research methodology we follow is a systematic approach in order to estimate and project the market sizing keeping in mind all the ongoing and upcoming trends of the market.
Competitive Landscape
Key players profiled in this report include (Sales Revenue, Price, Gross Margin, Main Products, etc.):
Acceleron Pharma
Epidestiny
Errant Gene Therapeutics
Gamida Cell
Pfizer Inc.
Global Blood Therapeutics
Hillhurst Biopharmaceuticals
Novartis
bluebird bio Inc.
Regenacy Pharmaceuticals
Through the successive chapters on the company, profiles provide deep insights on players operating in the Sickle Cell Disease Drug market. It focuses on the financial outlook of the key players, the status of R&D, strategies adopted, expansion strategies, and many more. Analysts preparing the report have offered a detailed list of the strategic initiatives adopted by the Sickle Cell Disease Drug market participants by referring past records and designing strategies to be adopted in the coming years. This enables the key players to stay ahead in the competition.
Regional Landscape
The chapter on regional segmentation details the regional aspects of the Sickle Cell Disease Drug market. This chapter explains the regulatory framework that is likely to impact the overall market. It highlights the political scenario in the market and anticipates its influence on the Sickle Cell Disease Drug market. Moreover, the report focuses on value and volume at the regional level, company level, and level.
Chapters covered under this report include:
Chapter 1, describes the Sickle Cell Disease Drug market reports - market overview, executive summary, and market scope. Further, the report adds a support base to identify the information and pick in relation to the aforementioned market
Chapter 2, defines the research methodology based on primary as well as secondary research, secondary data sources, and assumptions & exclusions
Chapter 3, description of Sickle Cell Disease Drug market in terms of its product scope, opportunities, drivers, restraints, and market risks
Chapter 4, the report offers a company profile of the top manufacturers of Sickle Cell Disease Drug market with its sales, revenue, share, and others
Chapter 5 and 6, to narrow down the sales data at the country level with shares, revenue, sand sales from 2018-2026
Chapter 7, the Sickle Cell Disease Drug market data is published based on a regional level and to show the revenue, sales, and growth on basis of the base year 2018, historical year: 2014-2018, estimated the year 2019 and Forecast year from 2019 to 2026
Chapter 8, describes the Sickle Cell Disease Drug market sales channels, distributors, research findings, appendix, and among others.
CHAPTER 1. INTRODUCTION
- 1.1. RESEARCH METHODOLOGY
- 1.1.1. ERC desk research
- 1.1.2. ERC data synthesis
- 1.1.3. Data validation and market feedback
- 1.1.4. ERC data sources
CHAPTER 2. SICKLE CELL DISEASE DRUG MARKET OVERVIEW
- 2.1. SICKLE CELL DISEASE DRUG MARKET INTRODUCTION
- 2.2. GLOBAL SICKLE CELL DISEASE DRUG MARKET PRODUCTION AND GROWTH RATE, 2017-2025
- 2.2.1. Global Sickle Cell Disease Drug Production (VOLUME) and Growth Rate (%), (2017-2025)
- 2.3. GLOBAL SICKLE CELL DISEASE DRUG MARKET CAPACITY AND GROWTH RATE, 2017-2025
- 2.3.1. Global Sickle Cell Disease Drug Capacity (VOLUME) and Growth Rate (%), (2017-2025)
- 2.4. GLOBAL SICKLE CELL DISEASE DRUG MARKET REVENUE AND GROWTH RATE, 2017-2025
- 2.4.1. Global Sickle Cell Disease Drug Market Revenue (Million USD) and Growth Rate (%), (2017-2025)
- 2.5. GLOBAL SICKLE CELL DISEASE DRUG MARKET CONSUMPTION AND GROWTH RATE, 2017-2025
- 2.5.1. Global Sickle Cell Disease Drug Consumption (VOLUME) and Growth Rate (%), (2017-2025)
- 2.6. GLOBAL SICKLE CELL DISEASE DRUG MARKET PRICE TREND, 2017-2025
- 2.6.1. Global Sickle Cell Disease Drug Market Price Trend and Growth Rate (%), (2017-2025)
CHAPTER 3. GLOBAL SICKLE CELL DISEASE DRUG MARKET BY DRUG TYPE, 2017-2025
- 3.1. ANTIBIOTICS
- 3.2. PAIN-RELIEVING MEDICATIONS
- 3.3. HYDROXYUREA
- 3.4. GLOBAL SICKLE CELL DISEASE DRUG MARKET REVENUE BY DRUG TYPE, 2017-2025
- 3.4.1. Global Sickle Cell Disease Drug Market Revenue (Million USD) and Share (%) By Drug type, 2017-2025
- 3.4.2. Antibiotics Market Revenue and Growth Rate, 2017-2025
- 3.4.3. Pain-relieving medications Market Revenue and Growth Rate, 2017-2025
- 3.4.4. Hydroxyurea Market Revenue and Growth Rate, 2017-2025
- 3.5. GLOBAL SICKLE CELL DISEASE DRUG MARKET PRODUCTION BY DRUG TYPE, 2017-2025
- 3.5.1. Global Sickle Cell Disease Drug Market Production (Volume) and Share (%) By Drug type, 2017-2025
- 3.5.2. Antibiotics Market Production and Growth Rate, 2017-2025
- 3.5.3. Pain-relieving medications Market Production and Growth Rate, 2017-2025
- 3.5.4. Hydroxyurea Market Production and Growth Rate, 2017-2025
Note: Similar information coverage has been provided for mode of administration segment.
CHAPTER 4. GLOBAL SICKLE CELL DISEASE DRUG MARKET BY DISEASE TYPE, 2017-2025
- 4.1. SICKLE CELL ANEMIA
- 4.2. SICKLE BETA THALASSEMIA
- 4.3. SICKLE HEMOGLOBIN C DISEASE
- 4.4. GLOBAL SICKLE CELL DISEASE DRUG MARKET REVENUE BY DISEASE TYPE, 2017-2025
- 4.4.1. Global Sickle Cell Disease Drug Market Revenue (Million USD) and Share (%) By Disease type, 2017-2025
- 4.4.2. Sickle cell anemia Market Revenue and Growth Rate, 2017-2025
- 4.4.3. Sickle beta thalassemia Market Revenue and Growth Rate, 2017-2025
- 4.4.4. Sickle hemoglobin c disease Market Revenue and Growth Rate, 2017-2025
- 4.5. GLOBAL SICKLE CELL DISEASE DRUG MARKET CONSUMPTION BY DISEASE TYPE, 2017-2025
- 4.5.1. Global Sickle Cell Disease Drug Market Consumption (Volume) and share (%) By Disease type, 2017-2025
- 4.5.2. Sickle cell anemia Market Consumption and Growth Rate, 2017-2025
- 4.5.3. Sickle beta thalassemia Market Consumption and Growth Rate, 2017-2025
- 4.5.4. Sickle hemoglobin c disease Market Consumption and Growth Rate, 2017-2025
Note: Similar information coverage has been provided for distributed channel segment.
CHAPTER 5. GLOBAL SICKLE CELL DISEASE DRUG MARKET BY REGION, 2017-2025
- 5.1. NORTH AMERICA
- 5.1.1. U.S.
- 5.1.2. Canada
- 5.1.3. Mexico
- 5.2. EUROPE
- 5.2.1. U.K.
- 5.2.2. France
- 5.2.3. Germany
- 5.2.4. Italy
- 5.2.5. Spain
- 5.2.6. Rest of Europe
- 5.3. ASIA PACIFIC
- 5.3.1. China
- 5.3.2. Japan
- 5.3.3. India
- 5.3.4. Korea
- 5.3.5. Rest of APAC
- 5.4. SOUTH AMERICA
- 5.4.1. Brazil
- 5.4.2. Rest of South America
- 5.5. REST OF THE WORLD
- 5.5.1. Middle East
- 5.5.2. Africa
- 5.6. GLOBAL SICKLE CELL DISEASE DRUG MARKET REVENUE BY REGION, 2017-2025
- 5.6.1. Global Sickle Cell Disease Drug Market Revenue (Million USD) and Share (%) By Region, 2017-2025
- 5.6.2. North America Market Revenue and Growth Rate, 2017-2025
- 5.6.3. Europe Market Revenue and Growth Rate, 2017-2025
- 5.6.4. Asia Pacific Market Revenue and Growth Rate, 2017-2025
- 5.6.5. South America Market Revenue and Growth Rate, 2017-2025
- 5.6.6. Rest of the World Market Revenue and Growth Rate, 2017-2025
CHAPTER 6. GLOBAL SICKLE CELL DISEASE DRUG MARKET PRODUCTION AND CONSUMPTION ANALYSIS BY REGION, 2017-2025
- 6.1. GLOBAL SICKLE CELL DISEASE DRUG MARKET PRODUCTION ANALYSIS BY REGION, 2017-2025
- 6.1.1. Global Sickle Cell Disease Drug Market Production (Volume) and Share (%) By Region, 2017-2025
- 6.1.2. Global Sickle Cell Disease Drug Market Consumption (Volume) and Share (%) By Region, 2017-2025
- 6.1.3. North America Market Production and Consumption, 2017-2025
- 6.1.4. Europe Market Production and Consumption, 2017-2025
- 6.1.5. Asia Pacific Market Production and Consumption, 2017-2025
- 6.1.6. South America Market Production and Consumption, 2017-2025
- 6.1.7. Rest of the World Market Production and Consumption, 2017-2025
CHAPTER 7. MARKET DETERMINANTS
- 7.1. MARKET DRIVERS
- 7.2. MARKET RESTRAINTS
- 7.3. MARKET OPPORTUNITIES
- 7.4. MARKET DETERMINANTS RADAR CHART
CHAPTER 8. GLOBAL SICKLE CELL DISEASE DRUG MARKET COMPETITION BY MANUFACTURERS
- 8.1. GLOBAL SICKLE CELL DISEASE DRUG PRODUCTION AND SHARE BY MANUFACTURERS (2017-2025)
- 8.1.1. Global Sickle Cell Disease Drug Production (VOLUME) and Share (%) by Manufacturers (2017-2025)
- 8.2. GLOBAL SICKLE CELL DISEASE DRUG REVENUE AND SHARE BY MANUFACTURERS (2017-2025)
- 8.2.1. Global Sickle Cell Disease Drug Revenue (Million USD) and Share (%) by Manufacturers (2017-2025)
- 8.3. SICKLE CELL DISEASE DRUG MARKET COMPETITIVE SITUATION AND TRENDS
- 8.3.1. Sickle Cell Disease Drug Market Share (%) of Top 3 Manufacturers
- 8.3.2. Sickle Cell Disease Drug Market Share (%) of Top 5 Manufacturers
CHAPTER 9. GLOBAL SICKLE CELL DISEASE DRUG MANUFACTURERS ANALYSIS
- 9.1. ACCELERON PHARMA
- 9.1.1. Business Overview
- 9.1.2. Company Basic Information
- 9.1.3. Sickle Cell Disease Drug Product Details
- 9.1.4. Acceleron Pharma Sickle Cell Disease Drug Production, Revenue and Gross Margin
- 9.2. EPIDESTINY
- 9.2.1. Business Overview
- 9.2.2. Company Basic Information
- 9.2.3. Sickle Cell Disease Drug Product Details
- 9.2.4. Epidestiny Sickle Cell Disease Drug Production, Revenue and Gross Margin
- 9.3. ERRANT GENE THERAPEUTICS
- 9.3.1. Business Overview
- 9.3.2. Company Basic Information
- 9.3.3. Sickle Cell Disease Drug Product Details
- 9.3.4. Errant Gene Therapeutics Sickle Cell Disease Drug Production, Revenue and Gross Margin
- 9.4. GAMIDA CELL
- 9.4.1. Business Overview
- 9.4.2. Company Basic Information
- 9.4.3. Sickle Cell Disease Drug Product Details
- 9.4.4. Gamida Cell Sickle Cell Disease Drug Production, Revenue and Gross Margin
- 9.5. PFIZER INC.
- 9.5.1. Business Overview
- 9.5.2. Company Basic Information
- 9.5.3. Sickle Cell Disease Drug Product Details
- 9.5.4. Pfizer Inc. Sickle Cell Disease Drug Production, Revenue and Gross Margin
- 9.6. GLOBAL BLOOD THERAPEUTICS
- 9.6.1. Business Overview
- 9.6.2. Company Basic Information
- 9.6.3. Sickle Cell Disease Drug Product Details
- 9.6.4. Global Blood Therapeutics Sickle Cell Disease Drug Production, Revenue and Gross Margin
- 9.7. HILLHURST BIOPHARMACEUTICALS
- 9.7.1. Business Overview
- 9.7.2. Company Basic Information
- 9.7.3. Sickle Cell Disease Drug Product Details
- 9.7.4. Hillhurst Biopharmaceuticals Sickle Cell Disease Drug Production, Revenue and Gross Margin
- 9.8. NOVARTIS
- 9.8.1. Business Overview
- 9.8.2. Company Basic Information
- 9.8.3. Sickle Cell Disease Drug Product Details
- 9.8.4. Novartis Sickle Cell Disease Drug Production, Revenue and Gross Margin
- 9.9. BLUEBIRD BIO, INC.
- 9.9.1. Business Overview
- 9.9.2. Company Basic Information
- 9.9.3. Sickle Cell Disease Drug Product Details
- 9.9.4. Bluebird bio, Inc. Sickle Cell Disease Drug Production, Revenue and Gross Margin
- 9.10. REGENACY PHARMACEUTICALS
- 9.10.1. Business Overview
- 9.10.2. Company Basic Information
- 9.10.3. Sickle Cell Disease Drug Product Details
- 9.10.4. Regenacy Pharmaceuticals Sickle Cell Disease Drug Production, Revenue and Gross Margin
CHAPTER 10. SICKLE CELL DISEASE DRUG MARKET VALUE CHAIN ANALYSIS
- 10.1. SICKLE CELL DISEASE DRUG INDUSTRIAL CHAIN ANALYSIS
- 10.2. SICKLE CELL DISEASE DRUG KEY RAW MATERIALS ANALYSIS
- 10.2.1. Key Raw Materials
- 10.2.2. Price Trend of Key Raw Materials
- 10.2.3. Key Suppliers of Raw Materials
- 10.3. MARKETING CHANNEL
- 10.3.1. Direct Marketing
- 10.3.2. Indirect Marketing
- 10.3.3. Distributors/Traders
- 10.4. CONSUMER ANALYSIS
- 10.4.1. Consumer 1
- 10.4.2. Consumer 2
- 10.4.3. Consumer 3
Summary:
Get latest Market Research Reports on Sickle Cell Disease Drug . Industry analysis & Market Report on Sickle Cell Disease Drug is a syndicated market report, published as Sickle Cell Disease Drug Market By Drug Type ( Antibiotics, Hydroxyurea, Pain-relieving medications ), By Mode of Administration ( Oral, Intravenous ), By Disease Type ( Sickle cell anemia, Sickle beta thalassemia, Sickle hemoglobin c disease ), By Distribution Channel ( Retail pharmacies, Hospital pharmacies, Online pharmacies ), Industry Trends, Estimation & Forecast, 2017 - 2025. It is complete Research Study and Industry Analysis of Sickle Cell Disease Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
